Dividend Assets Capital, LLC Takeda Pharmaceutical CO LTD Transaction History

Dividend Assets Capital, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $8,951 - $10,338	-670 Reduced 20.9%	2,536 $36,000
Q3 2023 Oct 26, 2023	SELL	$15.03 - $16.32 $129,258 - $140,352	-8,600 Reduced 72.84%	3,206 $50,000
Q2 2023 Jul 31, 2023	SELL	$15.57 - $17.11 $14,371 - $15,792	-923 Reduced 7.25%	11,806 $185,000
Q4 2022 Feb 10, 2023	SELL	$12.42 - $15.62 $15,611 - $19,634	-1,257 Reduced 8.99%	12,729 $199,000
Q2 2022 Jul 15, 2022	SELL	$13.12 - $15.03 $1,640 - $1,878	-125 Reduced 0.89%	13,986 $196,000
Q3 2021 Nov 01, 2021	SELL	$16.3 - $17.26 $8,198 - $8,681	-503 Reduced 3.44%	14,111 $231,000
Q2 2021 Jul 23, 2021	BUY	$16.55 - $18.64 $142,330 - $160,304	8,600 Added 143.0%	14,614 $246,000
Q1 2021 Apr 28, 2021	SELL	$16.71 - $19.9 $2,807 - $3,343	-168 Reduced 2.72%	6,014 $110,000
Q4 2020 Jan 22, 2021	BUY	$15.39 - $18.97 $95,140 - $117,272	6,182 New	6,182 $113,000
Q2 2020 Aug 03, 2020	SELL	$14.59 - $19.5 $365,654 - $488,709	-25,062 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$13.02 - $20.31 $122,804 - $191,563	-9,432 Reduced 27.34%	25,062 $380,000
Q4 2019 Feb 10, 2020	SELL	$16.88 - $20.83 $300,075 - $370,294	-17,777 Reduced 34.01%	34,494 $681,000
Q3 2019 Oct 25, 2019	SELL	$16.15 - $17.99 $279,750 - $311,622	-17,322 Reduced 24.89%	52,271 $899,000
Q2 2019 Jul 12, 2019	SELL	$16.58 - $20.49 $360,283 - $445,247	-21,730 Reduced 23.79%	69,593 $1.23 Million
Q1 2019 May 02, 2019	BUY	$16.7 - $21.52 $1.53 Million - $1.97 Million	91,323 New	91,323 $1.86 Million

318

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Dividend Assets Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Dividend Assets Capital, LLC with notifications on news.